Program
AURN001
A development code. Also written as “Combination Product: AURN001 + Y-27632” and “Cryopreserved AURN001”.
Its studies are mostly in Corneal Edema, led by Aurion Biotech.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Aurion Biotech | 32 open or running | phase 3since Jan 23, 2026 | Sep 11, 2023 | Jun 2027phase 3 · NCT07368959 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 11, 2023First study: phase 2 study in Corneal EdemaFirst studyNCT06041256 · 97 enrolled · United States, Canada
- Oct 4, 2024Phase 2 study in Corneal EdemaNCT06630169 · 25 enrolled · El Salvador
- Jan 23, 2026Phase 3 study in Corneal EdemaPhase 3 reachedNCT07368959 · 130 enrolled · United States
Ahead
- Jun 2027Primary completion: phase 3 study in Corneal EdemaNCT07368959
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07368959Corneal Edema · United States | 3 | Active, not recruiting | Jun 2027 | 130 |
| NCT06630169Corneal Edema · El Salvador | 2 | Active, not recruiting | Oct 2025 | 25 |
| NCT06041256Corneal Edema · United States, Canada | 2 | Completed | Oct 25, 2024 | 97 |
How it is read
Names in the registry
- “Combination Product: AURN001 + Y-27632”, 1 entry
- “AURN001”, 1 entry
- “Cryopreserved AURN001”, 1 entry
Codes read as this program: AURN001.
Conditions, from the studies’ own filings
- Corneal Edema, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.